Trial Outcomes & Findings for Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure Patients (NCT NCT00585611)
NCT ID: NCT00585611
Last Updated: 2019-03-26
Results Overview
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
1 participants
Primary outcome timeframe
6 months after initiation of intervention
Results posted on
2019-03-26
Participant Flow
While the record documents 1 participant enrolled in this study, there are no data available to report.
Participant milestones
| Measure |
Atorvastatin
Heart failure patients assigned to atorvastatin
Atorvastatin: Atorvastatin - 40 mg orally daily for 6 months
|
Arm 2
Atorvastatin: Atorvastatin - 40 mg orally daily for 6 months
placebo: placebo
|
|---|---|---|
|
Overall Study
STARTED
|
0
|
0
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure Patients
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: 6 months after initiation of interventionPopulation: There are no data available
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 months after initiation of interventionPopulation: There are no data available.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 months after initiation of interventionPopulation: There are no data available.
Outcome measures
Outcome data not reported
Adverse Events
Atorvastatin
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Arm 2
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place